University of Oslo (UiO) was founded in 1811 and is the largest institution of research and education in Norway with more than 30.000 students and more than 3.000 scientific staff. UiO has research in all areas of life sciences. Jointly with its four university hospitals Rikshospitalet Medical Centre which includes Radiumhospitalet Comprehensive Cancer Centre, and Ullevål, Aker and Akershus University Hospitals UiO forms a compact biomedical campus inside Oslo with tight connections between preclinical and clinical research, a strong translational research environment, state-of-the-art research infrastructure and well established training programmes.

 

UiO is coordinating its participation through the Centre for Molecular Medicine Norway (NCMM, www.ncmm.uio.no) a national centre for translational research established in 2007 as a partnership institution with the European Molecular Biology Laboratory together with similar centres in Sweden and Finland under the Nordic EMBL Partnership.

 

The overall objective of NCMM is to facilitate translation of discoveries in basic medical research into clinical practice. NCMM will focus particularly on disease mechanisms where Norway has clear strengths and will investigate mechanisms of non-communicable diseases such as cancer, cardiovascular and CNS-related disease and immune disorders.